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8. RENAL TRANSPLANTATION 
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It has now been more than 35 years since the first 
attempt was made at human renal homotransplantation. 
The early efforts to apply this form of therapy to the treat-
ment of terminal renal disease were doomed to failure since 
they preceded an appreciation of the problems to be 
encountered. Knowledge of homograft rejection was 
scanty and the therapy necessary to prevent this process 
was not understood at all. Since that time, a rational 
explanation of rejection has been provided by the studies 
of Medawar and those of other investigators. The evidence 
is overwhelming that rejection is due to immunologic 
repudiation of the alien tissue by the host. The intensity 
of this reaction is related to the degree of genetic dissimi-
larity between the donor and the recipient. Its prewntion 
depends to a greater or lesser extent upon crippling of the 
host's capacity for immunologic response to unfamiliar 
antigens. 
The initial attempts at potentiating homograft function 
by alteration of the host were made with total body 
irradiation. Such therapy proved to be of value for the 
prevention of rejection, but the requisite dosage was so 
high that most of the recipient patients died from bone 
marrow depression and sepsis. Despite the exorbitant 
risk imposed, two patients are stillli\ing from this pioneer 
era, the longest follow-ups being on two young men 
treated twehe years ago by Murray of Boston and by 
Hamburger with homografts from their fraternal twins. 
Today, there is no maj~r centre in the world using total 
body irradiation as an important element in the overall 
ther,j flY. 
In spite of the occasional early encouraging experience, 
the prospect of achieving significant clinical benefit from 
renal homotransplantation in more than the isolated 
case seemed remote indeed except when an identical twin 
donor was available (isograft) until the discowry by 
Schwartz and Dameshek of the immunosuppressi\'e pro-
perties of 6-mercaptopurine in 1959 and the subsequent 
testing of this drug and its analogue, azathioprine, by 
CaIne and Zukoski. It seemed that prewntion 0: homo-
graft rejection could be accomplished with greater regu-
lari:y and with les~ ri"k to the reciFient than had been 
pc~ssible with total bod\ irradiation: lon2-te:-r:', homo-
grdft viabilit: was achie\ed in anima1s~ with,:,u: the 
appearance of conCOmi13:1t hos: leukope!lla or a~~anulo­
c\!t'sis. During the ensuin2 se\cral ·Ie:-1q~K clll1ic;;,: efforts 
a', homotransplantation of the kidne~ haw p- ~DcDeeded 
\\ ilh fnEDrea~in:: re~ularityK B\ 1 (r I P.1,)re than -.))0 such 
potential!: th~rareutlc ~"perPIiDFns .... ere kn(,wn to ha\e 
been performed throughout the \'.c,rld by \irtue of their 
entr) int<> the American College of Surgeons oe~:stryI 
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Candidates for Homotransplantation 
The standard requirements for candidacy are simple. 
The patient should have irreversible renal disease from 
which life expectancy without dialysis or transplantation 
is limited to a few weeks or months. Recently, indirect 
indications for renal transplantation have come under 
evaluation. For example, kidneys have been gi\en to 
patients with completely normal renal function who were 
suffering from Fabris disease. Fabry's disease results 
from an inborn error of metabolism in which there is a 
deficiency of the enzyme ceramide trihexosidase with the 
consequent inability to hydrolyse the terminal galactose 
of ceramide trihexoside, which, therefore, accumulates in 
various tissues. The objective of renal transplantation in 
such cases is not to achieve specific organ function. but 
rather to prO\ide a source of enzyme. 
Just a few years ago, an obligatory condition for renal 
homotransplantation was a normal lower urinary traCt. 
More recently. it has been found possible to successfully 
implant homograft ureters to seriously diseased bladders, 
to correct mechanical bladder abnormalities before or 
simultaneously with transplantation or in some instances 
to perform transplantation with urinary drainage into an 
ileal loop. The reasonably good results in these relati\ely 
unfavourable situations illustrate the extent to which 
treatment by transplantation procedures has ad\anced. 
In other respects, the requirements have rela\ed for 
admission to transplantation progra mmes. Whereas 
serious disease in other organ systems used to rule out 
renal transplantation, this position is no longer support-
able. Finalk the age ceilim! has been risinl! steadIly. It 
is still true -that tra'nsplantation is best tol~rated b~D the 
relativelv young. ~eyerthelessK increasing numbers of 
recipients ha\e ~been treated in their 40's, ~RMDs and e\en 
60·s. 
Very frequently an interim period of intensive re;.uscita-
tiw therapy i, mandatory before a decision for or against 
tran;Dc~antation can be made. On many occ;:!,'c'ns a 
pr05pect'\e re·:ipient h3< entered the hospital in acute 
heart fallure \\lth severe h)penensi(ln. anasarca. 0: with a 
varier) of neurologic con:p1icatlom including pr,:·f0und 
COP.13 .. In mc"',;! in,t"rlce, these findmgs can be ;apidly 
re\er,ed b\' the imtitutic!1 l.f emerl!t'nc\ diahsis, If this 
prcnes to' be irr'F'ossitiie, the likcTjh,"'od or'suhequent 
six(.'es,ful transplan:ation I' redu.:ed, A si:,"'ficant 
impro\em<c:-1t j;; often neces;,a,: prwr to operati0n fClr 
the patient Ie> h3\'e a reasonable chance of tolerJ.ung the 
trauma of sur-ger; and the duress of the post-0r-:rative 
period. 
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Donor Selection 
Renal tissue is availableArom three general sources. 
First, there is now ample evidence that cadaveric kidneys 
can often provide good function. Recently, considerable 
success with such organs ihas been achieved by Kolff, 
Hume, Mowbray, and Hainburgt!r despite the fact that 
there is a high incidence of immediate functional failure 
of such kidneys, due primarily to ischremic injury. A 
Tik'lChni<qjllC of PC14 -
fusion o~ kidney "with (old oinK~1i14sf~EDtK~teK 
FIG. I. Method of cold perfusion of renal homograft. 
Various other solutions have been evaluated including 
low molecular weight Dextran, either alone or in com bina· 
tion with blood. plasma, or saline. All work relatively 
wcll. the prin~ipal beneficial effect being the rapidly in'· 
duced hypothermia. 
\ariable degree of damage is inevitable in the terminal 
premortem state of the dc'nor, to which is added an addi-
tional de\'ascularized period during remo\'3.1 and tramfer. 
The- h;:;rmful effecb of the latter "dead time" can be con· 
~iderabl~ minimlzed h:- gMickl~ cooling the kidne; after 
It, excIsion (Fie. 11. 
The i:11pr()\ed results ohtai:;ed b; the gr\.'ups cited abo\e 
haw !J;£e)\, beer. due to the \er\, carefull\ controlled 
circums:;:Jces of the undertaking. '\10s; of the recipient 
patients had been pre\iously n,aintained in good elir:l.::al 
condition on a chronic dial) sis pr._\gramme. When the 
cadaveric transplant was carried out it merely represented 
an incident in a programme of continuing therapy with the 
artificial kidney. Thm. patients who did not have im-
mediate homograft function could be maintained by an 
extension of their pre-existing care until recovery from 
an acute tubular necrosis in the homograft. Ultimately 
good function has been observed under such circumstances 
despite initial post-transplant anuria of as long as a month. 
Volunteer living donors provide a second source of 
renal homografts. Here, the entire procedure for both 
donor and recipient can be planned in advance and exe-
cuted with precision. The transplanted kidneys almost 
invariably work well immediately after operation since 
the donors are in good health, the ischremic intervals are 
short, and, in addition, the homografts can be further 
protected, just as with cadaveric kidneys, by perfusion 
with a cold electrolvte solution immediately after removal. 
Finally, it may ultimately become possible to use renal 
heterografts obtained from subhuman primate donors. 
Efforts have been made to transplant chimpanzee, baboon. 
and Rhesus kidne: 5 !() man, with surprisingly good and 
unexpectedly persistent function. The Rhesus heterograft 
transplanted bv Reemt5ma excreted urine in its human 
environment for almo"l a week, and the baboon kidneys 
used at the Lni\ersitv of Colorado functioned for ~s 
long as 2 months. One of oeemts~aDs patients, who 
received a pair or ck~lpanzee k.idneys, survived with 
good to fair renal function for 9 months. Despite these 
encouraging notes all :;0 patients treated with various 
heterografts are no\\ d~adI and it seems unlikely that 
consistent success can be obtained with the presently 
available immunosuppressive regimens. 
The source of the transplanted tissue has to date been 
the most important biologic determinant of success or 
failure. In controlled animal experiments, it has been 
established that the vigour of rejection is directly related to 
the degree of genetic dissimilarity between the donor and 
recipient. It is not surprising, therefore, that the best 
results have been when blood relatives have provided the 
homografts, as will be described in a subsequent section. 
Non-related donors have been less satisfactory. and the 
poorest results have been with heterografts. ]n -D~ff classes, 
however, the outcome is still unpredictable in the individual 
case. Violent and uncontrollable rejection episodes have 
occurred with familial homografts. Conversely, non· 
related homografts or even chimpanzee heterografts have 
on occasion incited little c1inicallv detectable host reaction. 
These findings suggest that a 'wide spectrum of donor-
recipient histocompatibility exists with employment of 
any of these donor pools. Until now, quanti tat ion of 
histocompatibility factors in the human has not been 
possible in a precise way. in spite of the effc'rh of a number 
of in\;"Qig3cNS. When suc'!; technique, become a\ailable. 
it will be pC'5sib1e :0 ma:ch the prospectJ\e rt'cirient with 
an apprc'priate d,:,'1»[, thereh~ eliminating mu,;-h of the 
gue~Ryyork in d,,[1'::': selection. 
Blood Group Considerations 
Wher. possible. donors and recipient5 are selectee of the 
same ABO blood gKr~"upsK This is not essential. howe\·er. 
.- ---~-K ------
84 SCIENT1FJC FOUNDATIONS OF SURGERY 
Vafious mismatch combinations appear not to carry 
an increased risk providing the transplant is not placed 
into a recipient whose plasma contains preformed hremag-
gliltinins directed against red cell antigens which are 
present in the renal cells of patients who belong to Blood 
Groups A, B, and AB. For example, a person of 0 type 
can provide a kidney for a recipient of any blood gro~p 
since the renal tissue of such a donor does not contam 
A or B isoantigens which could bind with hremagglutinins 
present in recipients of A, B, or 0 group. q~e 0 patient 
is thus the universal donor. Because the kIdney of an 
individual with AB blood contains both A and B isoanti-
gens, he could safely donate only to an AB recipient. 
Conversely, he could accept a kidney from any donor 
(universal recipient) since his plasma does not contain 
anti-A or anti-B hremagglutinins. The rules of tissue 
transfer across blood group barriers are, therefore, the 
same as those which apply to the use of non-matched 
blood in blood banks (Table 1). It is noteworthy that 
TABLE I 
DIRECTION OF ACCEPTABLE MISMATCHED TISSUE TRANSFER· 
o to non-O Safe 
Rh- to Rh+ Safe 
Rh+ to Rb- Relatively safe 
A to non-A Dangerous 
B to non-B Dangerous 
AB to non-AB Dangerous 
• 0 is universal donor. AB is universal recipient. 
long survival has been obtained despite violation of 
this scheme. One patient at the University of Colorado 
has normal renal function 9t years after B to A homo-
transplantation. Nevertheless, a number of immediate 
failures have occurred after similar mismatches, appar-
ently by a pathogenesis of antibody-mediated hyperacute 
rejection analogous (but with a different antibody) to that 
in the preceding section. 
SCRGICAL TECH,,\'QUES 
Both the donor and recipient operations involve the use 
of standard surgical techniques. Donor nephrectomy is 
more easily accomplished than nephrectomy in renal 
disease but it must be done with greater care in order to 
provide undamaged vessels and ureter for anastomosis. 
It is highly desirable, when living donors are used. or if 
brain death criteria are accepted for cada,eric donors. 
to perform pre-operatiw renal arteriography to deter-
mine if there are a~!o:na!ies of hlo(>d supply 
The recipierlt operation is also quitt.' SImple. OrdInarily. 
tht.' kidne~ IS pL:.:ed in the iliac fossa contral..tteral to ,ts 
donor loca!ic>n. re\ ersing the anteroposterior relatiorish;ps 
of the hilar stru('tures (Fig 2L In thi~ Wa\ the ureter a:ld 
pehi, are amerior. the ;enal artery in an intermediate 
positic1n. and the renal win posteric1r: The hM~l hY'pops::-ic 
artery and external iliac \ein are connected to the renal 
vessels: urinary drainage is provided by performing 
ureteronel')cysto,10my or ureteroureterostomy. L; nder 
various circumstances modifications of this technique are 
necessary either because of the small size of the recipient, 
or because of disease in the pelvic vessels. It is usually 
desirable and so~etimes obligatory to remove the recipient 
patient's own diseased kidneys either at the time of trans-
plantation or at a separate operation. This can easily be 
FIG. 2. Csual melhod of renal homolransplantatlOn. 
Depicled is the donor lefl kidney transplanted to the 
recipient'; right iliac fossa. 
done through a short upper midline incision. Under these 
circumstances, splenectomy is always performed at our 
centre. 
If a technically successful homotransplantation is 
carried out there is massive early post-operative diuresis. 
In unusual cases this has exceeded 100 ml per hour with 
the resultant need for meticulous management of fluid 
and electrolyte replacement. With this restoration of 
renal function there is a dramatic improvement in the 
patient's general condition, which persists until the time 
of homograft rejection. 
Tht' ElE:nts of Rejection 
The most Dg~efug II~enb for tht' prC\ention of rejectIon 
ha\e been azathlOpr,ne. c:-clc,phosphamide. prednisone. 
and heter0)ogom antilymphocyte globulin (-\ LG) A..l-
th.::>ugh thest.' aeent~ atter1L:ate the vif}.(lur of rejectil1 !"L 
the: ~ frequCltly- do not aJwgether p~nent its 'c):nical 
manifestation. A qUIte t)pical example of homograft 
rejection in a patie:lt receivinf immunosuppression IS 
illustrated in Fig 3. There yya~ excellent renal function 
j 
i 
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for more than two weeks after receipt of a homograft from 
his younger brother. His conval~scence was then inter-
rupted by an abrupt drop In ~reatfnfne clearance. relative 
oliguria. a secondar~K flse In blo?d-urea. fever •. ~nd 
proteinuria. The addItIon of prednIsone to pre-exIstIng 
therapy with azathioprine was followed by a reversal of 
all these adverse findings. 
PATIENT J. R. 
tAGE nd) 
loflllE 
OUTPUT 
(ee IdCIy) 
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E~/mfnF 
!lIN 
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(mgm/doy) 
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TM: IN OAYS 
FIG. 3. Classical rejection crisis in a patient being treated 
with the double drug combination of azathioprine 
(l muran I and prednisone. Deterioration of renal function 
began 17 days after transplantation. AU stigmata of 
rejection are present except for acute hypertension and 
weight gain. which were successfully prevented by 
medical treatment. The patient. w·hose transplantation 
was on 17 ApTiI. 1963. still has excellent function of the 
same homograft almost 10 years later. Blops: of the 
homograft after tv. 0 ,ears was normal. Acti-C -acll no-
mycin C; i~-left nephrectomy at the time of trans-
plantation; o~-right nephrectomy. 
The demonstration that most rejection episodes can be 
reversed is one of the fundamental disclosures which has 
made clinical homotransplantation a practical possi-
bility. Moreover. it is now clear that the drastic immuno-
suppressive measures frequently required for reversal of 
rejection are not needed permanently. Thus. in the patient 
de<;cribed (Fig. 3). the large doses of prednisone which 
were temporarily necessary could be quickly reduced. 
and in thi~ case the\' \\ ere discontinued altl,gether within 
~ I1h1!lths. The pa-tient still has perfect r';na) function 
J!:11l'st 10 years post-transplantation Such "bsena:ions 
D<lI;~est that Sl'me alteration occurs in the relationship 
r.et\\e.:n the homo£,aft and the host with the pa"a~e (,f 
time \\ hich din;ini~he~ the difficulty of CC1 f1trc,1::ng ;ege~-
1i,-'n. \\hether thi5 chan£e occurs in the h<FmcD~Iaft or in 
the host. or both. IS not tnown ~ 
Clinical Immunosuppression 
Drug Combinations 
A decade ago, in what has been termed the beginning 
of the modern era of transplantation, the double drug 
combination of azathioprine and prednisone was intro-
duced as the cornerstone of immunosuppressive therapy. 
In 1966. heterologous ALG raised in the horse against 
human lymphoid tissue was added in the formulation of a 
triple drug programme. The concept was (and is) that the 
A LG should be restricted to the early post-operative 
course when there was the greatest risk of rejection, and 
that with the hoped for "acceptance" of the transplant 
the globulin could be safely discontinued within a few 
weeks or months (Fig. 4). 
Within the last year, a new kind of triple drug therapy 
has been extensively evaluated in which the alkylating 
agent, cyclophosphamide, has been substituted for the 
purine analogue. azathioprine (Fig. 5). Even though these 
drugs are of different chemical classes and act at different 
phases of the cell cycle. they have proved to be about 
equally effective and, therefore, essentially interchange-
able in triple drug treatment. It remains to be determined. 
in view of the different metabolism of these t\\ 0 agents 
if they can be advantageously combined Epo~sibly serially) 
in some way which might permit a synergism \\hich has 
not hitherto been exploited. 
Th)'mectomy and splenectom~·K Although the tera-
peutic methods alluded to above are of more or less 
unquestioned value. two other biological manipulations 
have been carried out in many cases. Between 1962 and 
1966, thymectomy was performed prior to transplantation. 
primarily because of the evidence in rodent experiments by 
Miller that the thymus gland is important in the adult in 
re-establishing reactivity to foreign antigens after a period 
of immunological depression. Potential follow-ups of 
more than 5 years are now available for all these recipients 
and in each instance samples of the renal homografts have 
become available either by autopsy or biopsy. The extent 
of histopathologic abnormalities in these kidneys has been 
significantly less than in comparable patients whose 
thymus glands were not disturbed. In spite of this finding. 
which is the first evidence for potential function of the 
adult human thymus. the patient survival has not so far 
been beneficially influenced by thymectomy. Since com-
plete thymic excision can be a formidable undertaking in 
ura-mic humans. this ancillary procedure is not currently 
being performed in our patients pending further study of 
the remaining patients in the original series. 
As mentioned earlier. splenectomy is performed in all 
our patients who are swbmitted to laparotomy for neph-
rec-!>:lmies. The rationale is that the spleen participate, in 
an ea,dy demonstrable \\a: In the immunologic respon~e 
to Intra\enous antigen. There IS no proof that splenectom:-
impro\es suni\aJ after renal transplantation. but unlike 
th:meC'wm:-, splene.:-wmy is a simple prc)ced ure that 
does nOl require a sera~ate operaelon. Con~eguentlyK 
we continue to perform splenectomy In most of our 
patients. 
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Toxicity of Immunosuppressive Agents 
Essential though they are for maintenance of homo-
graft function, the agents used to protect the homograft 
do so by reJ)dering the patient more susceptible to a 
variety of inimical antigens. It is not surprising, therefore, 
that most of the failures after homotransplantation are due 
to complications of the agents used. A typical lethal 
change of events is shown in Figure 6. The young man 
concerned r~ceived a kidney from his brother. After 10 
WBC 
BUN 
mgm% 
2SPoo 
2OpOQ 
ISPOO 
URINE VOLlJv1E 4 
cc / day 3.000 
AZATHIOPRINE 
mgm/doy 
PREDNISONE 
mgm/doy 100 
200 
Pllp---~----__ --____ --__ ----~ 
-10 0 10 20 30 40 p,,, ~ (A'S ..1."0'- ~ "''''' TIME IN DAYS 
FIG. 6. Typical unsuccessfully treated case. The donor 
and recipient were brothers. both of A blood type. A 
violent rejection crisis followed good early function, 
and anuria developed which lasted two weeks. Although 
the rejection was re\ersed and a secondary diuresis began, 
the patient died from drug to)(icity. leukopenia and 
septica:mia. Anti-C-Each arrow is 200 pg intrayD~nous 
actinomycin C. 
days of good homograft function a severe rejection crisis 
supervened. with anuria. The rejection was reversed 
but after renal function had returned, the patient became 
leukopenic and died of a fungus and bacterial blood Sfream 
il1feuion. qhi~ complication is due to overdosage with 
aZJthioprine; the same kind of bone marro\\ depression 
':\.'c1ld be caused with cyclophosphamide. In recent years. 
earl: death, caused by e\cessive quantities of these c\'to-
w\ie drugs ha\e heen \inuall:- eliminated. -
At a later time. c(lntinumg immur.o,uppression. pa.-
tJe'ulJdy if large ma:nteilance do~es of prednis.)ne are 
required. can lead to infe .... tion ~ith opportunistic mj,:ro-
organisms for which high!; specific c.ntibiotic therap: is 
not a\ailable. Typically. these infections occur despite 
adequate peripheral white blood cell cpunts, and are 
caused predominantly by fungi. protozoa, and viruses. 
Bacteria that ordinarily have low pathogenicity such as 
Listeria monocytogenes are also seen I with increased 
frequency. One of the most serious public health hazards 
resulting from transplantation has been the creation of 
virus hepatitis reservoirs. Between 10 and 20 per cent of 
chronically surviving recipients of renal homografts come 
to have the Australia antigen in their serum which. once 
identified, tends to be a permanent finding. Even though 
liver function tests may be normal, these patients are 
hepatitis carriers and are capable of infecting other 
patients or members of the staff. 
An increased susceptibility to infection is not the only 
penalty to chronic immunosuppression. In the last five 
years, numerous de now malignancies have been reported 
in chronically surviving recipients of renal homografts. In 
our own centre, almost 10 per cent of the patients who 
were treated from 1962 to 1968 and who are still ali\e 
have developed a carcinoma (13 examples) or a Jympho-
reticular neoplasm (3 examples). In a world collection 
maintained in an informal basis in Denver, more than 70 
cases of de nOl'O malignancy have been compiled. The 
development of this striking complication provides an 
unwelcome clinical confirmation of Burnet's surveillance 
hypothesis, which holds that the immune system is nor-
mally responsible for the identification as "non-self" and 
the elimination of mutant cells. 
It should be emphasized that the increased risk from 
infection and malignancy does not vitiate the value of 
transplantation procedures. The infections can usually be 
controlled and the same has been true using conventional 
therapy with all but 2 of our 16 patients with neoplasias. 
In addition to its contribution to the foregoing side 
effects, prednisone causes facial and other changes which 
are an annoyance to most patients whose late renal func-
tion is dependent upon continuing steroid therapy. 
Pathological fractures have been described in such cases 
as well as the development of lens cataracts. 
Late Rejection 
As mentioned above, the necessity for intensive im-
munosuppressive therapy tends to decrease late after 
operation, and a number of patients have now been 
living for years with no clinical evidence of immunological 
activity directed against the homograft. Nevertheless. a 
significant number of long-term survivors have had mani-
festations of late rejection. sometimes in a form which 
resembles that seen early after operation. These late 
"crises" have proved to be partially re\ersible with the 
re5umption of large steroid doses. In such patients. the 
hc.mograft fun .... tion can be maintained. but the need for 
contin'Jou;; high dose stewid therapy constitutes a thre::t 
to a long life expectanc~K A more subtle form of late 
reiection withL,ut functional manifestations may be 
gc~lng on in the "chr·:;nic" hom"graft,. Kidneys biD:rsi~d 
or recovered at aU!0rs> I 10 2 :-ears after homot~arl;;­
plantation freque:1tly contain focal aggregate~ of mODe>-
nuclear celis, a \ ariet; of vascular lesion~ in both the 
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large and small vessels, lesions of the glomerular basement 
membrane and patchy interstitial fibrosis. These mor-
phologically damaged homografts may function in a quite 
satisfactory way for many years. However, they clearly 
do not have a normal life expectancy and such grafts have 
failed as late as 8 or 9 years after their insertion. Then, 
return to hremodialysis and/or retransplantation becomes 
necessary. 
Results and Future Prospects 
It is not the purpose of this chapter to present clinical 
data. Nevertheless, a brief statement is in order about 
what has been achieved so far. The modern era of whole-
organ transplantation began in late 1962 and early 1963, 
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FIG. 7. Life survival curves of 3 groups of recipients of 
consanguineous kidneys. The patients in series I were 
treated with the double drug programme of azathioprine 
and prednisone from 1962 to March 1964 and. conse-
quently have potential follow-ups of 8 to 91 years. The 
patients of series II were treated from October 1964 to 
April 1966 and. consequently, have potential follow-ups 
of 6 to 7! years. The) received the same drug therapy 
as in series I and. in addition, an attempt was made at 
donor selection by HL-A matching. Note that the 
tissue typing did not inftuence the survival cun·e. The 
recipients of series III '>'ere treated II.llh the triple drug 
programme of azathioprine. prednisone. and ALG 
hetween June 1966 and April 1968; they ha\e potential 
follow -ups of 4 to almost 6 years. In all three series, the 
denominator indicates the surviving patients whereas 
the numerator tells the number of originall} trans-
planted kidneys that are still functioning in those 
sUT\i\ors. 
from which era there are still about two dozen patients 
li\ing after haying had continuous subsequent function 
of their transplants, Since this time, thousands of patients 
ha\ e benefited from renal homotransplantation and have 
thereafta undergone rdativel;' ..::omplete so..::ial and 
\C • KK::a!l~Dnal rthabiliution. This has been parti..::ularly true 
In reClpJents of consan!:'uineous grafts who nov. can 
expec: to sun l\ e the f:r51- pest-tran;plantation vear at the 
rate of approximately 90 per cent ~ci£K h It;s les5 true 
of qeEipieD1t~ of unrelated (cada\eric) t~amplant;; in whom 
only bCi to 80 per cen, of gri:!ft~ fun..::tion f"r as lC'n£ as a 
yc-ar (Fig. 8l. After one \ear the los- rate of £TafLS and 
p:'lJents ha;; pw\ed to be at a \en slew ra~e in con-
~antuineom ('ases. With non-related'donors the outlook 
after one year is less optImistic. With both kinds of 
donors, the expsrience of the last decade has shown renal 
homotransplantation to be an exceptionally effective form 
of palliative treatment for patients with terminal renal 
disease. 
The research( and clinical experience with renal homo-
transplantation has direct application to the transplan-
tation of other organs. The immunosuppressive tech-
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FIG. 8. The results after the transplantation of non-
related kidnevs. The conditions of treatment. and 
follow 'ups, and the meaning of the figures in parentheses 
are the same as In Fig. 7. Note that the results with non-
related kIdneys ha\e been inferior to those with related 
grafts at all levels of our e:>.perience. 
niques developed with the kidney model have made 
possible the limited successes that have been achie\ed 
with hepatic, cardiac. and lung transplantation. There 
are a number of reasons for the high failure rate after 
transplantation of the extrarenal org;ns, but for the most 
part these reasons are non-immunologic. They include 
greater technical difficulties: the lack of artificial organs 
comparable to renal dialysis which could tide the hep~ticI 
cardiac, or pulmonary patient over transient periods of 
poor function: and e\ en the lack of discriminating tech· 
niques to diagnose rejection in its early and most reversible 
phases. 
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